TOP STORIES
respiratory
End-of-life care

How to change the mindset on referrals to palliative care for non-cancer respiratory disease?

Palliative care provides numerous benefits for people with non-cancer advanced respiratory disease, so why is it so little used for patients with a high levels of needs? Respiratory and palliative care physicians from Victoria have investigated why...

Palliative care provides numerous benefits for people with non-cancer advanced respiratory disease, so why is it so little...

Read more

News in Brief: Dramatic drop in bacterial pneumonia; Tighter glycaemic control improves lung function recovery in CF;  Vitamin D in moderation protective against respiratory infection

Lockdown has led to dramatic drop in bacterial pneumonia  Social distancing measures introduced to stave off COVID-19 infection have dramatically reduced paediatric thoracic empyema cases in Australia, report Melbourne clinicians. Respiratory and infectious disease specialists at The Royal...

Lockdown has led to dramatic drop in bacterial pneumonia  Social distancing measures introduced to stave off COVID-19 infection have...
Infectious diseases

Updated local advice on respiratory therapies during COVID-19

The Australasian Sleep Association has updated its consensus statement on the safe use of respiratory therapy and NIV to minimise aerosolisation of COVID-19. The statement acknowledges both the relatively low rates of...

The Australasian Sleep Association has updated its consensus statement on the...
ILD

Pirfenidone may improve results for patients with non-IPF fibrotic ILDs: RELIEF

Pirfenidone yielded improved outcome over placebo in a trial of patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (IPF). However, though the results were significant, the trial was terminated early due to slow recruitment,...

Pirfenidone yielded improved outcome over placebo in a trial of patients with progressive fibrotic interstitial lung diseases other...